Abstract
In the past five years, artificial intelligence has revolutionized healthcare by enabling earlier detection, diagnosis, and treatment of diseases. A recent breakthrough involves using eye-tracking technology to identify ocular biomarkers, aiding in the early detection of conditions like Alzheimer's and neurodegenerative diseases.
 Eye movement tests, previously costly and complex, have become accessible through smartphone and laptop cameras. These tests help detect a range of conditions, from degenerative disorders to brain injuries, improving patient outcomes and facilitating telehealth.
 This technology not only benefits patients but also advances the study of brain health. By delving into neurology and treatment efficacy, it may provide insights into the causes of neurodegenerative diseases.
 The future potential of gaze tracking is promising, with non-invasive, cost-effective systems offering hope for earlier diagnosis and treatment of neurodegenerative diseases, addressing a significant gap in healthcare. The eyes are not just windows to the soul but also a gateway to the brain's health.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
